Literature DB >> 11046079

Enhanced endothelin(A) receptor-mediated calcium mobilization and contraction in organ cultured porcine coronary arteries.

B J Hill1, L C Katwa, B R Wamhoff, M Sturek.   

Abstract

Arterial injury models for coronary artery disease have demonstrated an enhanced expression and function of either the endothelin(A) or endothelin(B) (ET(A) or ET(B)) receptor subtype. We hypothesized that organ culture would enhance the physiological function of ET receptors in the porcine right coronary artery. Arteries were either cold stored (4 degrees C) or organ cultured (37 degrees C) for 4 days. After 4 days, the artery was either 1) sectioned into rings to measure the ET-1-induced isometric tension response (3 x 10(-10)-3 x 10(-7) M), or 2) enzymatically dispersed and the isolated smooth muscle cells imaged using fura-2 to measure the myoplasmic calcium (Ca(m)) response to 3 x 10(-8) M ET-1 ( approximately EC(50)). Isometric tension and Ca(m) to ET-1 were measured in the absence and presence of bosentan (nonselective ET(A) or ET(B) receptor antagonist), BQ788 (ET(B)-selective antagonist), and BQ123 (ET(A)-selective antagonist). Compared with cold storage, organ culture induced a 2-fold increase in tension development (3 x 10(-7) M ET-1) and Ca(m) (3 x 10(-8) M ET-1), which was inhibited with bosentan, thus confirming the enhanced responses to ET-1 were due to ET receptor activation. BQ123 also inhibited the enhanced contraction and Ca(m) responses to ET-1. In contrast, BQ788 failed to inhibit tension development and Ca(m) responses to ET-1 in organ culture and cold storage. Sarafotoxin 6C (ET(B) agonist) failed to elicit an increased Ca(m) response in organ culture compared with cold storage. Our results indicate the increased tension development and Ca(m) responses to ET-1 in organ culture are attributable to ET(A) receptors, and not ET(B) receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046079

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Nongenomic inhibition of coronary constriction by 17ß-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol.

Authors:  Brent J F Hill; Senetibeb Gebre; Bonnie Schlicker; Renée Jordan; Sean Necessary
Journal:  Can J Physiol Pharmacol       Date:  2010-02       Impact factor: 2.273

2.  Effect of metabolic syndrome and aging on Ca2+ dysfunction in coronary smooth muscle and coronary artery disease severity in Ossabaw miniature swine.

Authors:  Jill K Badin; Rebecca S Bruning; Michael Sturek
Journal:  Exp Gerontol       Date:  2018-05-03       Impact factor: 4.032

3.  The enhanced endothelin-1-induced contraction in cultured coronary arteries from mature female pigs is not antagonized by 17beta-estradiol.

Authors:  Saigiridhar Tummala; Brent J F Hill
Journal:  Vascul Pharmacol       Date:  2006-12-09       Impact factor: 5.773

4.  Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine.

Authors:  Zachary P Neeb; Jason M Edwards; Mouhamad Alloosh; Xin Long; Eric A Mokelke; Michael Sturek
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

5.  Acute inhibition of the betaine transporter by ATP and adenosine in renal MDCK cells.

Authors:  Stephen A Kempson; Jason M Edwards; Alyssa Osborn; Michael Sturek
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-30

6.  Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis.

Authors:  Jason M Edwards; Zachary P Neeb; Mouhamad A Alloosh; Xin Long; Ian N Bratz; Cassandra R Peller; James P Byrd; Sanjay Kumar; Alexander G Obukhov; Michael Sturek
Journal:  Cardiovasc Res       Date:  2009-09-10       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.